NYSE: NVO
Novo Nordisk A S Stock Ownership - Who owns Novo Nordisk (Ozempic)?

Insider buying vs selling

Have Novo Nordisk A S insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when NVO insiders and whales buy or sell their stock.

NVO Shareholders

What type of owners hold Novo Nordisk A S stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Jennison Associates LLC0.42%18,885,343$1.08BInstitution
Bank Of America Corp0.33%14,721,478$842.07MInstitution
Morgan Stanley0.32%14,284,790$817.09MInstitution
Fmr LLC0.31%13,941,160$797.43MInstitution
Loomis Sayles Co L P0.28%12,576,031$719.35MInstitution
Capital International Investors0.26%11,621,232$664.73MInstitution
Fisher Asset Management LLC0.25%11,000,916$629.25MInstitution
Fayez Sarofim Co0.24%10,503,662$600.81MInstitution
Folketrygdfondet0.23%10,094,543$577.41MInstitution
Kingstone Capital Partners Texas LLC0.22%10,005,216$572.30MInstitution

1 of 3

NVO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NVO6.89%0.00%
VRTX93.82%1.51%Net SellingNet Selling
REGN68.94%31.06%Net Selling
ALNY82.81%17.19%Net SellingNet Selling
ARGX52.63%0.00%

Novo Nordisk (Ozempic) Stock Ownership FAQ

Who owns Novo Nordisk (Ozempic)?

Novo Nordisk (Ozempic) (NYSE: NVO) is owned by 6.89% institutional shareholders, 0.00% Novo Nordisk (Ozempic) insiders, and 93.11% retail investors. Jennison Associates LLC is the largest individual Novo Nordisk (Ozempic) shareholder, owning 18.89M shares representing 0.42% of the company. Jennison Associates LLC's Novo Nordisk (Ozempic) shares are currently valued at $1.10B.

If you're new to stock investing, here's how to buy Novo Nordisk (Ozempic) stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.